View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Northrim BanCorp Earns $13.3 Million, or $2.38 Per Diluted Share, in F...

Northrim BanCorp Earns $13.3 Million, or $2.38 Per Diluted Share, in First Quarter 2025 ANCHORAGE, Alaska, April 23, 2025 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $13.3 million, or $2.38 per diluted share, in the first quarter of 2025, compared to $10.9 million, or $1.95 per diluted share, in the fourth quarter of 2024, and $8.2 million, or $1.48 per diluted share, in the first quarter a year ago. The increase in first quarter 2025 profitability as compared to the first quarter a year ago was primarily the result o...

 PRESS RELEASE

King Salman Park Foundation Selects Parsons for Project Management Off...

King Salman Park Foundation Selects Parsons for Project Management Office Services CHANTILLY, Va., April 23, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that it has been awarded a contract for Project Management Office (PMO) services by the King Salman Park Foundation for King Salman Park. This 25-month contract marks new work for Parsons. King Salman Park is one of the world's most unique urban transformation projects, featuring 11.6 sq km of green space and over 10 sq km of built-up area. The Park includes cultural landmarks such as the Royal Arts Complex an...

 PRESS RELEASE

Noodles & Company to Announce First Quarter 2025 Results on May 7, 202...

Noodles & Company to Announce First Quarter 2025 Results on May 7, 2025 BROOMFIELD, Colo., April 17, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) today announced that it will host a conference call to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025 at 4:30 p.m. ET. Drew Madsen, Chief Executive Officer, and Mike Hynes, Chief Financial Officer, will host the call. A press release with first quarter 2025 financial results will be issued after the market close that same day. The conference call can be accessed live over the phone by dialing 201-389-092...

 PRESS RELEASE

OPKO Health to Report First Quarter 2025 Financial Results on April 30...

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesday, April 30, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on April 30th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to p...

 PRESS RELEASE

Parsons Selected for Southwest Florida International Airport Terminal ...

Parsons Selected for Southwest Florida International Airport Terminal Expansion CHANTILLY, Va., April 16, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today it was selected by the Lee County Port Authority to provide project management services for Phase 1 of the Southwest Florida International Airport (RSW) Terminal Expansion Project in Fort Myers, Florida.  "We are honored to support the Lee County Port Authority to ensure the successful delivery of Phase 1 of the transformative Terminal Expansion Project,” said Mark Fialkowski, president of Infrastructure North...

 PRESS RELEASE

Parsons Wins Seat on $1.5 Billion Air Force Civil Engineering Center E...

Parsons Wins Seat on $1.5 Billion Air Force Civil Engineering Center Environmental Services Contract Addressing PFAS CHANTILLY, Va., April 14, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a seat on a $1.5 billion indefinite-delivery, indefinite-quantity multiple award task order contract by the Air Force Civil Engineering Center (AFCEC) to provide architect-engineer services addressing environmental issues, including emerging contaminants such as per- and polyfluoroalkyl substances (PFAS). The contract includes a five-year base peri...

 PRESS RELEASE

Parsons Awarded $24 Million Naval Medical Research Command Biodefense ...

Parsons Awarded $24 Million Naval Medical Research Command Biodefense Contract CHANTILLY, Va., April 07, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a biological defense research contract to advance the Naval Medical Research Command’s (NMRC) mission to defend against the threat of biological and chemical warfare. The $24 million contract consists of a one-year base period and four one-year option periods. Under this contract, Parsons will continue to support NMRC’s Biological Defense Research Directorate (BDRD) in their effor...

 PRESS RELEASE

OPKO Health Announces $100 Million Increase to its Existing Share Repu...

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200 million. Approximately $41 million of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024. “We believe OPKO’s shares continue to be significantly undervalued and offer an attractive...

 PRESS RELEASE

Parsons to Announce First Quarter 2025 Financial Results on April 30, ...

Parsons to Announce First Quarter 2025 Financial Results on April 30, 2025 CHANTILLY, Va., April 03, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) will release first quarter 2025 financial results before the markets open on Wednesday, April 30, 2025. The company will host a conference call at 8:00 a.m. Eastern Time that day to discuss its earnings results and strategic corporate initiatives. Access to a webcast of the live conference call can be obtained through the Investor Relations section of the company's website (). Those parties interested in participating via telephone ...

 PRESS RELEASE

Parsons Selected for PFAS Investigation and Remedy Development at Tucs...

Parsons Selected for PFAS Investigation and Remedy Development at Tucson International Airport CHANTILLY, Va., April 02, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced that the company was selected by Tucson Airport Authority (TAA), operator of Tucson International Airport (TUS), to execute a per- and polyfluoroalkyl substances (PFAS) facility investigation. The professional services agreement contract includes source area delineation, offsite source differentiation, and remedy feasibility assessment associated with TAA’s required use of PFAS containing aqueous film fo...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: April 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 28, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Parsons’ Board Approves $250 Million Share Repurchase Authorization

Parsons’ Board Approves $250 Million Share Repurchase Authorization CHANTILLY, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that its board of directors has increased the company’s stock repurchase authorization to $250 million. “Parsons’ strong operating results and cash flow allow us to increase share repurchases while simultaneously executing on our strategic plan of investing in accretive organic and inorganic growth opportunities,” said Parsons’ Chair, President, and Chief Executive Officer Carey Smith. “Our integrated solutions, demonstrate...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 22, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Opko Health Inc: 1 director

A director at Opko Health Inc bought 200,000 shares at 1.739USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advan...

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and license agreement to advance into the clinic the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for patients with obesity, metabolic and fibrotic disorders. ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch